DOI:
10.1055/s-00034922
Arthritis und Rheuma
Issue 04 ·
Volume 39 ·
August 2019
DOI: 10.1055/s-009-43944
Editorial
213
Fiehn, Christoph;
Strangfeld, Anja:
Schwerpunkt
219
Stammschulte, Thomas;
Köberle, Ursula;
Peter, Hans-Hartmut;
Pitzer, Martina;
Gundert-Remy, Ursula:
Drug safety and pharmacovigilance from the point of view of the Drug Commission of the German Medical Association
226
Weber-Schoendorfer, Corinna:
Safety of antirheumatic drugs in pregnancy: Recommendations of Embryotox
234
Klotsche, Jens;
Niewerth, Martina;
Minden, Kirsten:
Drug safety in the management of rheumatic diseases in children and adolescents – results of JuMBO
242
Nigg, Axel Philipp;
Feuchtenberger, Martin:
Rare adverse effects of biological DMARDs
249
Leipe, Jan:
Safety of JAK inhibitors
Kinderrheumatologie | Übersichtsartikel
253
Vogt, Annika;
Stieler, Karola Maria;
Blume-Peytavi, Ulrike:
Skin manifestations of underlying rheumatologic diseases in children and adolescents
Kasuistik Kinderrheumatologie
261
Markowsky, A;
Pommerenke, M;
Gutmann, D;
Windschall, D:
Verbandsnachrichten
266
268
Robbers, Jörg RA;
Lakomek, Heinz-Jürgen:
Buchbesprechung
270
